Jump to content

Amsterdam, 2017 Industry-corrupted psychiatric trials


andy013
 Share

Recommended Posts

Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29432499

doi: 10.12740/PP/80136

Full text: http://psychiatriapolska.pl/uploads/images/PP_6_2017/ENGver993Amsterdam_PsychiatrPol2017v51i6.pdf

Industry-corrupted psychiatric trials

Jay D. Amsterdam, Leemon B. McHenry, Jon N. Jureidini

 

Abstract

The goal of this paper is to expose the research misconduct of pharmaceutical industry sponsored clinical trials via three short case studies of corrupted psychiatric trials that were conducted in the United States. We discuss the common elements that enable the misrepresentation of clinical trial results including ghostwriting for medical journals, the role of key opinion leaders as co-conspirators with the pharmaceutical industry and the complicity of top medical journals in failing to uphold standards of science and peer review. We conclude that the corruption of industry-sponsored clinical trials is one of the major obstacles facing evidence-based medicine.

 

 

December 2010: 10mg Citalopram

April 2011: 5mg for 2 weeks then cold turkey withdrawal - Extremely bad depression / no emotions

June 2011: Reinstated 10mg - After 3 weeks started getting impulsive suicidal thoughts

July 2011: Cold turkey - Withdrawal hell begins...

 

January 2021: Reinstated 0.1mg Citalopram as last resort

February 2021: 0.2mg Citalopram for 2 days had bad foggy head so went back down to 0.1mg

Upon reducing I experienced low mood, suicidal thoughts, burning up, low appetite, very bad insomnia, mild diarrhoea

22 Feb 2021: Stopped all Citalopram after panic / depression attack and crying similar to when I reinstated back in June 2011.

Link to comment
Share on other sites

 Share

×
×
  • Create New...

Important Information

Terms of Use Privacy Policy